Promsorn J, Naknan P, Sookprasert A, Wirasorn K, Chindaprasirt J, Titapun A
Heliyon. 2024; 10(7):e28805.
PMID: 38617950
PMC: 11015104.
DOI: 10.1016/j.heliyon.2024.e28805.
Quan B, Li M, Lu S, Li J, Liu W, Zhang F
Front Oncol. 2022; 12:824541.
PMID: 35530339
PMC: 9071301.
DOI: 10.3389/fonc.2022.824541.
Lee J, Kim H, Sohn H, Choi Y, Kang J, Han Y
Ann Surg Treat Res. 2022; 102(2):100-109.
PMID: 35198513
PMC: 8831089.
DOI: 10.4174/astr.2022.102.2.100.
Jung P, Cho E, Kim S, Kim R
Ann Hepatobiliary Pancreat Surg. 2019; 23(4):319-326.
PMID: 31824996
PMC: 6893051.
DOI: 10.14701/ahbps.2019.23.4.319.
Skipworth J, Keane M, Pereira S
Dig Dis. 2014; 32(5):570-8.
PMID: 25034290
PMC: 4158615.
DOI: 10.1159/000360507.
Postoperative radiotherapy dose correlates with locoregional control in patients with extra-hepatic bile duct cancer.
Im J, Seong J, Lee J, Kim Y, Lee I, Park J
Radiat Oncol J. 2014; 32(1):7-13.
PMID: 24724046
PMC: 3977131.
DOI: 10.3857/roj.2014.32.1.7.
Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery.
Koh H, Park H, Kim K, Chie E, Min H, Ha S
Radiat Oncol J. 2013; 30(4):197-204.
PMID: 23346539
PMC: 3546288.
DOI: 10.3857/roj.2012.30.4.197.
Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.
Skipworth J, Olde Damink S, Imber C, Bridgewater J, Pereira S, Malago M
Aliment Pharmacol Ther. 2011; 34(9):1063-78.
PMID: 21933219
PMC: 3235953.
DOI: 10.1111/j.1365-2036.2011.04851.x.
Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients.
Sakamoto Y, Shimada K, Nara S, Esaki M, Ojima H, Sano T
J Gastrointest Surg. 2009; 14(2):335-43.
PMID: 19902311
DOI: 10.1007/s11605-009-1072-7.
Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma.
Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H
J Gastrointest Surg. 2009; 13(8):1470-9.
PMID: 19421824
DOI: 10.1007/s11605-009-0900-0.
Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions.
Allen P, Reiner A, Gonen M, Klimstra D, Blumgart L, Brennan M
HPB (Oxford). 2008; 10(5):341-6.
PMID: 18982150
PMC: 2575674.
DOI: 10.1080/13651820802276630.
Staging of extrahepatic cholangiocarcinoma.
Chung Y, Kim M, Park Y, Lee Y, Choi J
Eur Radiol. 2008; 18(10):2182-95.
PMID: 18458911
DOI: 10.1007/s00330-008-1006-x.
Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis.
Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T
World J Surg. 2006; 31(2):337-42.
PMID: 17006609
DOI: 10.1007/s00268-006-0224-0.
Klatskin tumor treated by inter-disciplinary therapies including stereotactic radiotherapy: a case report.
Becker G, Momm F, Schwacha H, Hodapp N, Usadel H, Geissler M
World J Gastroenterol. 2005; 11(31):4923-6.
PMID: 16097074
PMC: 4398752.
DOI: 10.3748/wjg.v11.i31.4923.
Photodynamic therapy for pancreatic and biliary tract carcinoma.
Ayaru L, Bown S, Pereira S
Int J Gastrointest Cancer. 2005; 35(1):1-13.
PMID: 15722569
DOI: 10.1385/IJGC:35:1:001.
Actual long-term outcome of extrahepatic bile duct cancer after surgical resection.
Jang J, Kim S, Park D, Ahn Y, Yoon Y, Choi M
Ann Surg. 2004; 241(1):77-84.
PMID: 15621994
PMC: 1356849.
DOI: 10.1097/01.sla.0000150166.94732.88.
Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis.
Puhalla H, Gruenberger T, Pokorny H, Soliman T, Wrba F, Sponer U
World J Surg. 2003; 27(6):680-4.
PMID: 12733000
DOI: 10.1007/s00268-003-6656-x.
Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience.
Tsao J, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M
Ann Surg. 2000; 232(2):166-74.
PMID: 10903592
PMC: 1421125.
DOI: 10.1097/00000658-200008000-00003.
Extended resections for hilar cholangiocarcinoma.
Neuhaus P, Jonas S, Bechstein W, Lohmann R, Radke C, Kling N
Ann Surg. 2000; 230(6):808-18; discussion 819.
PMID: 10615936
PMC: 1420945.
DOI: 10.1097/00000658-199912000-00010.
Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures.
Zidi S, Prat F, Le Guen O, RONDEAU Y, Pelletier G
Gut. 1999; 46(1):103-6.
PMID: 10601064
PMC: 1727781.
DOI: 10.1136/gut.46.1.103.